...
首页> 外文期刊>BMC Cancer >Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium
【24h】

Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium

机译:肿瘤浸润的CD8 + T细胞与卵巢癌患者细胞增殖相关的预后影响-OVCAD联盟的研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Epithelial ovarian cancer is one of the most lethal gynecologic malignancies. Clinicopathological factors do not permit precise prognosis and cannot provide guidance to specific treatments. In this study we assessed tumor infiltrating CD8+ T cells in association with Ki67 proliferation index and evaluated their prognostic impact in EOC samples. Methods CD8+ cells and Ki67 proliferation index were immunohistochemically determined on tissue microarrays including 203 primary epithelial ovarian tumors. Additionally, CD8 gene expression was assessed with RT-qPCR. Correlations were analyzed using Pearson’s correlation coefficients, ANOVA or T-test, or Fischer’s exact tests. Prognostic impact was evaluated using the Kaplan-Meier method and Cox regression model. Results The density of CD8+ infiltrating lymphocytes did not correlate with tumor cell proliferation. Epithelial ovarian cancer patients with no Ki67+ cells in the tumor had a more than three times higher risk to die compared to the population with Ki67+ cells in the tumor (Hazard ratio (HR)?=?3.34, 95%CI 1.59-7.04). High CD8+ cell infiltration was associated with improved overall survival (HR?=?0.82, 95%CI 0.73-0.92). Conclusions The density of tumor infiltrating lymphocytes is independent of tumor cell proliferation. Ovarian cancer patients with Ki67- tumors showed a significantly reduced overall survival, presumably due to no or poor response to platinum-based chemotherapy. Moreover, the association of high densities of tumor infiltrating cytotoxic T lymphocytes with a better overall survival was confirmed.
机译:背景上皮性卵巢癌是最致命的妇科恶性肿瘤之一。临床病理因素不能准确预后,也不能为具体治疗提供指导。在这项研究中,我们评估了肿瘤浸润的CD8 + T细胞与Ki67增殖指数的关系,并评估了其对EOC样品的预后影响。方法采用免疫组织化学方法检测203例原发性上皮性卵巢肿瘤组织中的CD8 +细胞和Ki67增殖指数。另外,用RT-qPCR评估CD8基因表达。相关性使用Pearson相关系数,ANOVA或T检验或Fischer精确检验进行了分析。使用Kaplan-Meier方法和Cox回归模型评估预后影响。结果CD8 +浸润淋巴细胞的密度与肿瘤细胞的增殖无关。与肿瘤中具有Ki67 +细胞的人群相比,肿瘤中没有Ki67 +细胞的上皮性卵巢癌患者死亡风险高三倍以上(危险比(HR)?=?3.34,95%CI 1.59-7.04)。高CD8 +细胞浸润与总生存期改善有关(HR = 0.82,95%CI 0.73-0.92)。结论肿瘤浸润淋巴细胞的密度与肿瘤细胞的增殖无关。患有Ki67肿瘤的卵巢癌患者总体生存率显着降低,大概是由于对铂类化学疗法没有反应或反应较差。而且,证实了高密度的肿瘤浸润性细胞毒性T淋巴细胞与更好的总生存期的关联。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号